Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.214.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.610NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQNWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
KP.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDPNWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.214.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XEBNWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDP.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
KF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XBB.1.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
C.36.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XBB.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
GK.1.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
JN.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
KB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19777.6South Korea
B.1.599NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19777.6South Korea
B.1.599NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19788.4Germany
BA.2.3.6NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-19797.4US
FL.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19812.6China
DV.6.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDBNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used